Q1 2018 Brainstorm Cell Therapuetics Inc Earnings Call
Llamada en conferencia Brainstorm Cell Therapuetics Inc
Brainstorm Cell Therapuetics Inc Conference call will be held on 14-may-2018. During the earnings conference call's session Brainstorm Cell Therapuetics Inc will provide updated information and financial status.
Conference call is also referred to as: teleconference call or audio conference bridge. Conferencing service is provided in house or as cloud based teleconference service.
In order to join the audio conferencing dial conference bridge and key in the PIN code, Contact Brainstorm Cell Therapuetics Inc for this information
Schedule an online conference with QCONF conference service and get 5 free calls with online conferencing.
We are a biotechnology company developing novel adult stem cell therapies for debilitating neurodegenerative disorders such as Amyotrophic Lateral Sclerosis ("ALS", also known as Lou Gehrig's disease), Multiple Sclerosis ("MS"), and Parkinson's disease ("PD") among others. These diseases for the most part have no or limited treatment options and as such represent unmet medical needs. We believe that NurOwn®, our proprietary process for the propagation of Mesenchymal Stem Cells ("MSC") and their differentiation into neurotrophic factor-("NTF") secreting cells ("MSC-NTF"), and their transplantation at, or near, the site of damage, offers the hope of more effectively treating neurodegenerative diseases. Our core technology was developed in collaboration with Prof. Daniel Offen of the Felsenstein Medical Research Center of Tel Aviv University and the late Prof.Leer más Llamada en conferencia